Targeted therapy of respiratory syncytial virus in African green monkeys by intranasally administered 2-5A antisense

Virology

Volumn 292, Issue 1, 2002, Pages 70-77

  Leaman, Douglas W ^a,b   Longano, Frank J ^a   Okicki, James R ^a   Soike, Kenneth F ^d   Torrence, Paul F ^c   Silverman, Robert H ^b   Cramer, Hagen ^a  

^a Ridgeway Biosystems Inc   (United States)

^b LERNER RESEARCH INSTITUTE   (United States)

^c NORTHERN ARIZONA UNIVERSITY   (United States)

^d TULANE NATIONAL PRIMATE RESEARCH CENTER   (United States)

Author keywords

2 O methyl antisense; Ribonuclease L

Indexed keywords

NIH 351; OLIGONUCLEOTIDE; RB 1034; RB 1035; RB 1045; RB 1062; RB 1063; RB 1064; RB 1065; RB 1066; RIBONUCLEASE; RIBONUCLEASE L; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL MODEL; ANTIVIRAL ACTIVITY; ARTICLE; CERCOPITHECIDAE; CHIMERA; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; DRUG EFFECT; DRUG SPECIFICITY; DRUG STABILITY; GENE SEQUENCE; NONHUMAN; PRIORITY JOURNAL; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VIRUS GENOME; VIRUS INFECTION; VIRUS REPLICATION;

CERCOPITHECUS AETHIOPS; RESPIRATORY SYNCYTIAL VIRUS; RICE STRIPE VIRUS;

EID: 0036061381     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.2001.1213     Document Type: Article

References (29)

1. A semi-automated neutral red based chemosensitivity assay for drug screening
2. Targeting RNA decay with 2′,5′ oligoadenylate-antisense in respiratory syncytial virus-infected cells
3. Discrimination between ribonuclease H- and ribonuclease L-mediated RNA degradation by 2′-O-methylated 2-5A-antisense oligonucleotides
4. Synthesis and hybridization studies on two complementary nona(2′-O-methyl)ribonucleotides
5. 2′-O-alkyl oligoribonucleotides as antisense probes
6. Inhibition of respiratory syncytial virus replication by antisense oligodeoxyribonucleotides
7. A human respiratory syncytial virus (RSV) primate model of enhanced pulmonary pathology induced with a formalin-inactivated RSV vaccine but not a recombinant FG subunit vaccine
8. Activation of 2-5A-dependent RNase by analogs of 2-5A (5′-O-triphosphoryladenylyl(2′-5′)adenylyl (2′-5′) adenosine) using 2′,5′-tetraadenylate (core)-cellulose
9. Respiratory syncytial virus puzzle: Clinical features, pathophysiology, treatment, and prevention
10. Controlling gene expression with 2-5A antisense
11. Relative thermodynamic stability of DNA, RNA, and DNA:RNA hybrid duplexes: Relationship with base composition and structure
12. Blockage of NF-kappa B signaling by selective ablation of an mRNA target by 2-5A antisense chimeras
13. Nucleotide sequences of the 3′ leader and 5′ trailer regions of human respiratory syncytial virus genomic RNA
14. DNA antisense therapy for asthma in an animal model
15. Potent inhibition of respiratory syncytial virus replication using a 2-5A-antisense chimera targeted to signals within the virus genomic RNA
16. Methods for the characterization of phosphatase-stabilized 2-5A-antisense chimeras
17. The 2-5A system: Modulation of viral and cellular processes through acceleration of RNA degradation
18. Bronchiolitis-associated mortality and estimates of respiratory syncytial virus-associated deaths among US children, 1979-1997
19. Use of disposable micro-tissues culture plates for antiviral and interferon induction studies
20. Targeting RNA for degradation with a (2′-5′)oligoadenylate-antisense chimera
21. Recruiting the 2-5A system for antisense therapeutics
22. 2,5-Oligoadenylate-peptide nucleic acids (2-5A-PNAs) activate RNase L
23. Intranasal monoclonal IgA antibody to respiratory syncytial virus protects rhesus monkeys against upper and lower respiratory tract infection
24. Respiratory syncytial virus (RSV) disease and prospects for its control
25. Nuclease-resistant composite 2′,5′-oligoadenylate-3′, 5′-oligonucleotides for the targeted destruction of RNA: 2-5A-iso-antisense
26. Synthesis and characterization of composite nucleic acids containing 2′, 5′-oligoriboadenylate linked to antisense DNA